Quarterly Institutional Activity in ATXI

Shares Bought
Shares Sold
View Transactions

Top Institutions Holding ATXI

View all

Latest Institutional Activity in ATXI

Top Purchases

Q2 2023
Shikiar Asset Management Inc Shares Held: 25K ($49.3K)
Q1 2023
Icon Wealth Partners, LLC Shares Held: 40K ($78.8K)
Q2 2022
Renaissance Technologies LLC Shares Held: 124K ($245K)
Q2 2022
Hrt Financial LP Shares Held: 39.1K ($77K)
Q2 2022
Susquehanna International Group, LLP Shares Held: 25.7K ($50.6K)

Top Sells

Q3 2022
Vanguard Group Inc Shares Held: 0 ($0)
Q3 2022
Black Rock Inc. Shares Held: 0 ($0)
Q2 2022
Virtu Financial LLC Shares Held: 0 ($0)
Q2 2022
Tower Research Capital LLC (Trc) Shares Held: 3.14K ($6.18K)
Q2 2022
Two Sigma Securities, LLC Shares Held: 26.2K ($51.5K)

About ATXI

Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.


Insider Transactions at ATXI

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.75M Shares
From 4 Insiders
Open market or private purchase 500 shares
Grant, award, or other acquisition 2.75M shares
Sell / Disposition
617K Shares
From 2 Insiders
Open market or private sale 617K shares

Track Institutional and Insider Activities on ATXI

Follow AVENUE THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATXI shares.

Notify only if

Insider Trading

Get notified when an Avenue Therapeutics, Inc. insider buys or sells ATXI shares.

Notify only if

News

Receive news related to AVENUE THERAPEUTICS, INC.

Track Activities on ATXI